US Stock MarketDetailed Quotes
APTO Aptose Biosciences
- 0.2785
- +0.0054+1.98%
Trading Nov 21 10:27 ET
5.44MMarket Cap-95P/E (TTM)
0.3018High0.2743Low67.80KVolume0.3018Open0.2731Pre Close19.15KTurnover0.47%Turnover RatioLossP/E (Static)19.52MShares2.907752wk High-0.60P/B4.05MFloat Cap0.270152wk Low--Dividend TTM14.54MShs Float1457.9988Historical High--Div YieldTTM10.07%Amplitude0.2701Historical Low0.2820Avg Price1Lot Size
About Aptose Biosciences Company
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Company Profile
SymbolAPTO
Company NameAptose Biosciences
Listing DateOct 23, 2014
Founded1986
CEODr. William G. Rice, PhD
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
AddressTD Bank Tower,66 Wellington Street West,Suite 5300
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5K 1E6
Phone1-647-479-9828
Websitehttp://www.aptose.com
Company Executives
- Name
- Position
- Salary
- Dr. William G. Rice, PhD
- President, Chief Executive Officer and Chairman of the Board
- 924.67K
- Dr. Rafael Bejar, M.D.,PhD
- Senior Vice President and Chief Medical Officer
- 750.08K
- Fletcher Payne
- Principal Accounting Officer, Senior Vice President, Chief Financial Officer, Corporate Secretary and Chief Business Officer
- 611.37K
- Dr. Bernd R. Seizinger, M.D.,PhD
- Independent Director
- 132.17K
- Carol Gail Ashe
- Independent Director
- 123.67K
- Dr. Denis R. Burger,PhD
- Lead Independent Director
- 172.17K
- Warren Whitehead
- Independent Director
- 122.68K
- Dr. Erich M. Platzer, M.D.,PhD
- Independent Director
- 123.67K
- Dr. Mark D. Vincent, M.D.
- Independent Director
- 127.68K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data